• 1. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 2. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 3. Fc microparticles can modulate the physical extent and magnitude of complement activity?
  David White,Sean R. Stowell Biomater. Sci., 2017,5, 463-474
• 4. Emulsion soft templating of carbide-derived carbon nanospheres with controllable porosity for capacitive electrochemical energy storage?
  M. Zeiger,N. J?ckel,P. Strubel,L. Borchardt,R. Reinhold,W. Nickel,J. Eckert,V. Presser,S. Kaskel J. Mater. Chem. A, 2015,3, 17983-17990
• 5. Excitation dependent bidirectional electron transfer in phthalocyanine-functionalised MoS2 nanosheets?
  Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283

• Solvents and Organic Chemicals Organic Compounds cyanides/Cyanides

Recent Advances in the Study of 5-methyl-1H-pyrazole-4-carbonitrile (CAS: 131661-41-1) and Its Applications in Chemical Biology and Pharmaceutical Research

5-methyl-1H-pyrazole-4-carbonitrile (CAS: 131661-41-1) is a heterocyclic compound that has garnered significant attention in recent years due to its versatile applications in chemical biology and pharmaceutical research. This compound serves as a key intermediate in the synthesis of various biologically active molecules, including kinase inhibitors, antimicrobial agents, and anti-inflammatory drugs. Recent studies have explored its potential in drug discovery and development, particularly in targeting specific enzymatic pathways and modulating protein-protein interactions. This research brief aims to summarize the latest findings related to 5-methyl-1H-pyrazole-4-carbonitrile, highlighting its synthetic utility, biological activities, and therapeutic potential.

One of the most notable advancements in the study of 5-methyl-1H-pyrazole-4-carbonitrile is its role in the development of kinase inhibitors. Kinases are critical regulators of cellular signaling pathways, and their dysregulation is often associated with cancer and other diseases. Researchers have successfully utilized 5-methyl-1H-pyrazole-4-carbonitrile as a scaffold to design potent and selective kinase inhibitors. For instance, a recent study published in the Journal of Medicinal Chemistry demonstrated that derivatives of this compound exhibited strong inhibitory activity against cyclin-dependent kinases (CDKs), which are implicated in cell cycle progression and tumor growth. The study reported IC50 values in the nanomolar range, suggesting high potency and specificity.

In addition to its applications in kinase inhibition, 5-methyl-1H-pyrazole-4-carbonitrile has also been investigated for its antimicrobial properties. A 2023 study in the European Journal of Medicinal Chemistry revealed that certain derivatives of this compound displayed broad-spectrum activity against Gram-positive and Gram-negative bacteria, including drug-resistant strains such as methicillin-resistant Staphylococcus aureus (MRSA). The researchers attributed this activity to the compound's ability to disrupt bacterial cell wall synthesis and inhibit essential enzymes involved in bacterial metabolism. These findings underscore the potential of 5-methyl-1H-pyrazole-4-carbonitrile as a lead compound for the development of novel antibiotics.

Another area of interest is the anti-inflammatory potential of 5-methyl-1H-pyrazole-4-carbonitrile derivatives. A recent preclinical study published in Bioorganic & Medicinal Chemistry Letters explored the effects of these compounds on inflammatory mediators such as cyclooxygenase-2 (COX-2) and tumor necrosis factor-alpha (TNF-α). The results indicated that certain derivatives significantly reduced inflammation in animal models, with minimal side effects. This suggests that 5-methyl-1H-pyrazole-4-carbonitrile-based compounds could serve as promising candidates for the treatment of chronic inflammatory diseases, such as rheumatoid arthritis and inflammatory bowel disease.

The synthetic versatility of 5-methyl-1H-pyrazole-4-carbonitrile has also been a focal point of recent research. Advances in organic chemistry have enabled the development of efficient and scalable synthetic routes for this compound and its derivatives. For example, a 2022 study in Organic Letters described a novel one-pot synthesis method that significantly improved the yield and purity of 5-methyl-1H-pyrazole-4-carbonitrile. This methodological innovation has facilitated the rapid exploration of its chemical space, allowing researchers to generate diverse libraries of derivatives for biological screening.

Despite these promising developments, challenges remain in the clinical translation of 5-methyl-1H-pyrazole-4-carbonitrile-based therapeutics. Issues such as bioavailability, metabolic stability, and toxicity need to be addressed through further optimization and preclinical testing. However, the growing body of research on this compound underscores its potential as a valuable tool in drug discovery. Future studies are expected to focus on structure-activity relationship (SAR) analyses, pharmacokinetic profiling, and in vivo efficacy evaluations to advance these compounds toward clinical trials.

In conclusion, 5-methyl-1H-pyrazole-4-carbonitrile (CAS: 131661-41-1) represents a versatile and promising scaffold in chemical biology and pharmaceutical research. Its applications in kinase inhibition, antimicrobial activity, and anti-inflammatory effects highlight its broad therapeutic potential. Continued research and development efforts are likely to yield novel drug candidates based on this compound, addressing unmet medical needs in oncology, infectious diseases, and inflammatory disorders. This research brief provides a snapshot of the current state of knowledge and underscores the importance of further investigation into this intriguing molecule.

• 88054-15-3(1H-Pyrazole, 4,5-dimethyl-)
• 138134-09-5(3-isopropyl-1H-pyrazole-4-carbonitrile)
• 51445-36-4((3-Methyl-1H-pyrazol-4-yl)methanol)
• 5519-42-6(3,4,5-Trimethyl-1H-pyrazole)
• 108161-12-2(3,5-Dimethyl-1H-pyrazole-4-carbonitrile)
• 88893-75-8(4-Methyl-1H-pyrazole-3-carbonitrile)
• 2820-37-3(4,5-dimethyl-1H-pyrazole)
• 202842-99-7(3,4-Dimethyl-1H-pyrazole Hydrochloride)
• 875554-79-3(3-tert-Butyl-1H-pyrazole-4-carbonitrile)
• 49772-49-8(3,6-dimethyl-4,5-Pyridazinedicarbonitrile)